FDA Warning Letter — Navinta, LLC
The FDA took a Warning Letter action against Navinta, LLC on September 26, 2016 (Ewing, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Navinta, LLC
- Date
- September 26, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Center
- CDER
- Location
- Ewing, NJ (United States)